Amarin Corporation plc (AMRN)
USD 0.4
(-6.25%)
USD 0.4
(-6.25%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 831.68 Million USD | -6.15% |
| 2022 | 886.17 Million USD | -17.03% |
| 2021 | 1.06 Billion USD | 10.56% |
| 2020 | 966.02 Million USD | 9.5% |
| 2019 | 882.2 Million USD | 128.72% |
| 2018 | 385.71 Million USD | 138.69% |
| 2017 | 161.59 Million USD | -3.23% |
| 2016 | 166.99 Million USD | -3.73% |
| 2015 | 173.46 Million USD | 1.38% |
| 2014 | 171.1 Million USD | -32.23% |
| 2013 | 252.47 Million USD | -18.78% |
| 2012 | 310.85 Million USD | 145.97% |
| 2011 | 126.37 Million USD | 257.34% |
| 2010 | 35.36 Million USD | -37.07% |
| 2009 | 56.19 Million USD | 53.3% |
| 2008 | 36.65 Million USD | -13.25% |
| 2007 | 42.25 Million USD | -13.46% |
| 2006 | 48.82 Million USD | 4.42% |
| 2005 | 46.76 Million USD | 97.12% |
| 2004 | 23.72 Million USD | -49.93% |
| 2003 | 47.37 Million USD | -51.43% |
| 2002 | 97.53 Million USD | 7.19% |
| 2001 | 90.99 Million USD | 87.24% |
| 2000 | 48.59 Million USD | 43.98% |
| 1999 | 33.75 Million USD | 104.56% |
| 1998 | 16.5 Million USD | -58.96% |
| 1997 | 40.2 Million USD | -10.47% |
| 1996 | 44.9 Million USD | 26.12% |
| 1995 | 35.6 Million USD | 0.0% |
| 1993 | 24.2 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 790.01 Million USD | -5.01% |
| 2024 Q3 | 750.61 Million USD | -6.16% |
| 2024 Q2 | 799.85 Million USD | 1.25% |
| 2023 Q3 | 839.03 Million USD | -2.44% |
| 2023 Q1 | 860.18 Million USD | -2.93% |
| 2023 Q2 | 860.01 Million USD | -0.02% |
| 2023 FY | 831.68 Million USD | -6.15% |
| 2023 Q4 | 831.68 Million USD | -0.88% |
| 2022 FY | 886.17 Million USD | -17.03% |
| 2022 Q1 | 973.7 Million USD | -8.83% |
| 2022 Q2 | 973.23 Million USD | -0.05% |
| 2022 Q4 | 886.17 Million USD | -2.44% |
| 2022 Q3 | 908.3 Million USD | -6.67% |
| 2021 Q3 | 1.03 Billion USD | -0.88% |
| 2021 Q2 | 1.04 Billion USD | 5.53% |
| 2021 FY | 1.06 Billion USD | 10.56% |
| 2021 Q4 | 1.06 Billion USD | 3.11% |
| 2021 Q1 | 990.25 Million USD | 2.51% |
| 2020 Q2 | 914.86 Million USD | -1.17% |
| 2020 Q1 | 925.66 Million USD | 4.93% |
| 2020 Q3 | 960.2 Million USD | 4.96% |
| 2020 Q4 | 966.02 Million USD | 0.61% |
| 2020 FY | 966.02 Million USD | 9.5% |
| 2019 Q2 | 389.92 Million USD | 4.75% |
| 2019 Q1 | 372.23 Million USD | -3.49% |
| 2019 FY | 882.2 Million USD | 128.72% |
| 2019 Q4 | 882.2 Million USD | 1.76% |
| 2019 Q3 | 866.93 Million USD | 122.34% |
| 2018 Q4 | 385.71 Million USD | 83.42% |
| 2018 FY | 385.71 Million USD | 138.69% |
| 2018 Q1 | 215.7 Million USD | 33.48% |
| 2018 Q2 | 204.13 Million USD | -5.37% |
| 2018 Q3 | 210.28 Million USD | 3.02% |
| 2017 Q3 | 166.61 Million USD | -2.1% |
| 2017 FY | 161.59 Million USD | -3.23% |
| 2017 Q1 | 175.2 Million USD | 4.91% |
| 2017 Q2 | 170.18 Million USD | -2.86% |
| 2017 Q4 | 161.59 Million USD | -3.01% |
| 2016 FY | 166.99 Million USD | -3.73% |
| 2016 Q3 | 193.9 Million USD | 31.34% |
| 2016 Q4 | 166.99 Million USD | -13.87% |
| 2016 Q2 | 147.63 Million USD | -3.32% |
| 2016 Q1 | 152.71 Million USD | -11.96% |
| 2015 FY | 173.46 Million USD | 1.38% |
| 2015 Q3 | 182.42 Million USD | -6.53% |
| 2015 Q1 | 215.33 Million USD | 25.85% |
| 2015 Q2 | 195.16 Million USD | -9.37% |
| 2015 Q4 | 173.46 Million USD | -4.91% |
| 2014 Q3 | 185.37 Million USD | -9.94% |
| 2014 Q1 | 220.2 Million USD | -12.78% |
| 2014 Q2 | 205.83 Million USD | -6.52% |
| 2014 Q4 | 171.1 Million USD | -7.7% |
| 2014 FY | 171.1 Million USD | -32.23% |
| 2013 FY | 252.47 Million USD | -18.78% |
| 2013 Q1 | 271.33 Million USD | -12.71% |
| 2013 Q2 | 214.66 Million USD | -20.88% |
| 2013 Q4 | 252.47 Million USD | -14.08% |
| 2013 Q3 | 293.84 Million USD | 36.88% |
| 2012 Q4 | 310.85 Million USD | 21.9% |
| 2012 Q3 | 254.99 Million USD | -5.97% |
| 2012 FY | 310.85 Million USD | 145.97% |
| 2012 Q2 | 271.17 Million USD | 3.96% |
| 2012 Q1 | 260.84 Million USD | 106.4% |
| 2011 Q3 | 131.67 Million USD | -2.84% |
| 2011 Q1 | 132.8 Million USD | 275.51% |
| 2011 FY | 126.37 Million USD | 257.34% |
| 2011 Q2 | 135.52 Million USD | 2.04% |
| 2011 Q4 | 126.37 Million USD | -4.02% |
| 2010 Q4 | 35.36 Million USD | 0.0% |
| 2010 FY | 35.36 Million USD | -37.07% |
| 2010 Q2 | 38.74 Million USD | 0.0% |
| 2009 FY | 56.19 Million USD | 53.3% |
| 2009 Q2 | 25.87 Million USD | 0.0% |
| 2009 Q4 | 56.19 Million USD | 0.0% |
| 2008 FY | 36.65 Million USD | -13.25% |
| 2008 Q2 | 49.55 Million USD | 54.05% |
| 2008 Q1 | 32.16 Million USD | -23.88% |
| 2007 Q4 | 42.25 Million USD | 70.96% |
| 2007 Q2 | 31.07 Million USD | -25.1% |
| 2007 Q1 | 41.48 Million USD | -15.03% |
| 2007 FY | 42.25 Million USD | -13.46% |
| 2007 Q3 | 24.71 Million USD | -20.46% |
| 2006 Q2 | 40.55 Million USD | -11.79% |
| 2006 FY | 48.82 Million USD | 4.42% |
| 2006 Q4 | 48.82 Million USD | 41.57% |
| 2006 Q3 | 34.49 Million USD | -14.95% |
| 2006 Q1 | 45.97 Million USD | -1.68% |
| 2005 Q4 | 46.76 Million USD | 0.0% |
| 2005 Q2 | 28.9 Million USD | 0.0% |
| 2005 FY | 46.76 Million USD | 97.12% |
| 2004 Q4 | 23.72 Million USD | 96.07% |
| 2004 Q3 | 12.09 Million USD | -0.35% |
| 2004 Q2 | 12.14 Million USD | 0.0% |
| 2004 FY | 23.72 Million USD | -49.93% |
| 2003 Q2 | 68.31 Million USD | 0.0% |
| 2003 FY | 47.37 Million USD | -51.43% |
| 2003 Q4 | 47.37 Million USD | -65.55% |
| 2003 Q3 | 137.54 Million USD | 101.35% |
| 2002 Q4 | 97.53 Million USD | 0.0% |
| 2002 FY | 97.53 Million USD | 7.19% |
| 2001 Q4 | 90.99 Million USD | 0.0% |
| 2001 FY | 90.99 Million USD | 87.24% |
| 2000 Q4 | 48.59 Million USD | 0.0% |
| 2000 FY | 48.59 Million USD | 43.98% |
| 1999 FY | 33.75 Million USD | 104.56% |
| 1998 FY | 16.5 Million USD | -58.96% |
| 1998 Q3 | 16.5 Million USD | 0.0% |
| 1997 Q3 | 40.2 Million USD | 0.0% |
| 1997 FY | 40.2 Million USD | -10.47% |
| 1996 Q3 | 44.9 Million USD | 0.0% |
| 1996 FY | 44.9 Million USD | 26.12% |
| 1995 FY | 35.6 Million USD | 0.0% |
| 1995 Q3 | 35.6 Million USD | 0.0% |
| 1993 FY | 24.2 Million USD | 0.0% |
| 1993 Q3 | 24.2 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| AbCellera Biologics Inc. | 1.48 Billion USD | 44.111% |
| Alkermes plc | 2.13 Billion USD | 61.068% |
| Agenus Inc. | 313.91 Million USD | -164.941% |
| Alnylam Pharmaceuticals, Inc. | 3.82 Billion USD | 78.284% |
| Aptorum Group Limited | 20.64 Million USD | -3929.459% |
| Ardelyx, Inc. | 297.57 Million USD | -179.483% |
| Arrowhead Pharmaceuticals, Inc. | 765.55 Million USD | -8.638% |
| Bicycle Therapeutics plc | 595.34 Million USD | -39.698% |
| BioXcel Therapeutics, Inc. | 73.7 Million USD | -1028.442% |
| ChromaDex Corporation | 54.96 Million USD | -1413.143% |
| Chimerix, Inc. | 212.77 Million USD | -290.877% |
| Corbus Pharmaceuticals Holdings, Inc. | 28.27 Million USD | -2841.682% |
| Caribou Biosciences, Inc. | 440.96 Million USD | -88.604% |
| CRISPR Therapeutics AG | 2.22 Billion USD | 62.698% |
| Precision BioSciences, Inc. | 159.78 Million USD | -420.515% |
| Dyadic International, Inc. | 8.21 Million USD | -10018.751% |
| Eton Pharmaceuticals, Inc. | 31.74 Million USD | -2520.302% |
| Fortress Biotech, Inc. | 167.52 Million USD | -396.451% |
| Lantern Pharma Inc. | 43.64 Million USD | -1805.451% |
| HOOKIPA Pharma Inc. | 161.33 Million USD | -415.495% |
| Inhibikase Therapeutics, Inc. | 14.5 Million USD | -5633.124% |
| Incyte Corporation | 6.78 Billion USD | 87.737% |
| IO Biotech, Inc. | 150.71 Million USD | -451.815% |
| Jaguar Health, Inc. | 50.76 Million USD | -1538.367% |
| Novavax, Inc. | 1.85 Billion USD | 55.174% |
| Janux Therapeutics, Inc. | 380.4 Million USD | -118.63% |
| Opthea Limited | 188.79 Million USD | -340.531% |
| Ligand Pharmaceuticals Incorporated | 833.06 Million USD | 0.166% |
| ContextLogic Inc. | 423 Million USD | -96.616% |
| MiMedx Group, Inc. | 239.04 Million USD | -247.917% |
| Pyxis Oncology, Inc. | 173.72 Million USD | -378.733% |
| TransCode Therapeutics, Inc. | 5.16 Million USD | -15987.662% |
| NextCure, Inc. | 129.41 Million USD | -542.634% |
| Ocuphire Pharma, Inc. | 53.94 Million USD | -1441.64% |
| Oncternal Therapeutics, Inc. | 36.72 Million USD | -2164.38% |
| Outlook Therapeutics, Inc. | 32.3 Million USD | -2474.793% |
| Vaxcyte, Inc. | 1.4 Billion USD | 40.928% |
| PDS Biotechnology Corporation | 59.39 Million USD | -1300.375% |
| Madrigal Pharmaceuticals, Inc. | 640.54 Million USD | -29.84% |
| Pharming Group N.V. | 462.85 Million USD | -79.686% |
| Pieris Pharmaceuticals, Inc. | 38.68 Million USD | -2050.165% |
| Avidity Biosciences, Inc. | 628.55 Million USD | -32.317% |
| Reviva Pharmaceuticals Holdings, Inc. | 18.92 Million USD | -4294.939% |
| Reviva Pharmaceuticals Holdings, Inc. | 18.92 Million USD | -4294.939% |
| Sangamo Therapeutics, Inc. | 165.32 Million USD | -403.075% |
| Sol-Gel Technologies Ltd. | 45.28 Million USD | -1736.474% |
| Acelyrin, Inc. | 742.69 Million USD | -11.983% |
| Salarius Pharmaceuticals, Inc. | 6.58 Million USD | -12527.057% |
| SELLAS Life Sciences Group, Inc. | 6.4 Million USD | -12888.974% |
| Summit Therapeutics Inc. | 202.94 Million USD | -309.8% |
| Sensei Biotherapeutics, Inc. | 74.37 Million USD | -1018.246% |
| Senti Biosciences, Inc. | 119.48 Million USD | -596.063% |
| Stoke Therapeutics, Inc. | 228.34 Million USD | -264.227% |
| Syros Pharmaceuticals, Inc. | 168.17 Million USD | -394.538% |
| Alaunos Therapeutics, Inc. | 8.26 Million USD | -9965.158% |
| Telomir Pharmaceuticals, Inc. Common Stock | 4.77 Million USD | -17321.961% |
| Entrada Therapeutics, Inc. | 469.19 Million USD | -77.259% |
| VistaGen Therapeutics, Inc. | 123.65 Million USD | -572.595% |
| Wave Life Sciences Ltd. | 274.94 Million USD | -202.487% |
| Sorrento Therapeutics, Inc. | 472.84 Million USD | -75.891% |
| TRACON Pharmaceuticals, Inc. | 10.1 Million USD | -8130.421% |
| Barinthus Biotherapeutics plc | 214.5 Million USD | -287.721% |
| Psyence Biomedical Ltd. | 1.13 Million USD | -73360.0% |
| Phathom Pharmaceuticals, Inc. | 413.84 Million USD | -100.967% |
| Immix Biopharma, Inc. | 19.92 Million USD | -4074.039% |
| Keros Therapeutics, Inc. | 370.02 Million USD | -124.764% |
| MEI Pharma, Inc. | 41.37 Million USD | -1910.112% |
| Windtree Therapeutics, Inc. | 32.4 Million USD | -2466.451% |
| Xeris Biopharma Holdings, Inc. | 340.79 Million USD | -144.04% |
| Rigel Pharmaceuticals, Inc. | 117.22 Million USD | -609.477% |
| Fortress Biotech, Inc. | 167.52 Million USD | -396.451% |
| Precigen, Inc. | 151.04 Million USD | -450.627% |
| Clearside Biomedical, Inc. | 34.01 Million USD | -2344.835% |
| AlloVir, Inc. | 190.79 Million USD | -335.902% |
| C4 Therapeutics, Inc. | 376.45 Million USD | -120.928% |
| Fate Therapeutics, Inc. | 506.21 Million USD | -64.294% |
| ImmuCell Corporation | 43.8 Million USD | -1798.471% |
| IDEAYA Biosciences, Inc. | 649.31 Million USD | -28.086% |
| Onconetix, Inc. | 88.82 Million USD | -836.355% |
| PureTech Health plc | 693.97 Million USD | -19.844% |
| VYNE Therapeutics Inc. | 97.68 Million USD | -751.394% |
| Elevation Oncology, Inc. | 89.09 Million USD | -833.522% |
| Kintara Therapeutics, Inc. | 6.2 Million USD | -13309.932% |
| Seer, Inc. | 436.26 Million USD | -90.636% |
| Verrica Pharmaceuticals Inc. | 81.59 Million USD | -919.258% |
| Innoviva, Inc. | 1.24 Billion USD | 33.118% |
| Aadi Bioscience, Inc. | 132.42 Million USD | -528.051% |
| ESSA Pharma Inc. | 149.12 Million USD | -457.72% |
| GlycoMimetics, Inc. | 45.31 Million USD | -1735.28% |
| GT Biopharma, Inc. | 14.1 Million USD | -5794.706% |
| Inhibrx Biosciences, Inc. | 307.89 Million USD | -170.121% |
| Akebia Therapeutics, Inc. | 241.7 Million USD | -244.093% |
| Catalyst Pharmaceuticals, Inc. | 471.9 Million USD | -76.239% |
| Longboard Pharmaceuticals, Inc. | 50.69 Million USD | -1540.499% |
| Orchestra BioMed Holdings, Inc. | 95.21 Million USD | -773.508% |
| Alzamend Neuro, Inc. | 631.58 Thousand USD | -131581.413% |
| Rocket Pharmaceuticals, Inc. | 566.34 Million USD | -46.852% |
| Aptose Biosciences Inc. | 12.92 Million USD | -6335.915% |
| ZyVersa Therapeutics, Inc. | 22.11 Million USD | -3660.845% |
| Soligenix, Inc. | 9.79 Million USD | -8388.888% |
| Century Therapeutics, Inc. | 360.69 Million USD | -130.581% |
| Kura Oncology, Inc. | 448.93 Million USD | -85.257% |
| TScan Therapeutics, Inc. | 272.14 Million USD | -205.599% |
| Intensity Therapeutics, Inc. | 17.29 Million USD | -4708.812% |
| Ocean Biomedical, Inc. | 110.91 Million USD | -649.864% |
| CytomX Therapeutics, Inc. | 205.15 Million USD | -305.401% |
| Autolus Therapeutics plc | 375.38 Million USD | -121.557% |
| Mineralys Therapeutics, Inc. | 251.63 Million USD | -230.511% |
| EyePoint Pharmaceuticals, Inc. | 355.18 Million USD | -134.156% |
| Eterna Therapeutics Inc. | 49.13 Million USD | -1592.754% |
| Adaptive Biotechnologies Corporation | 661.13 Million USD | -25.797% |
| GRI Bio, Inc. | 2.95 Million USD | -28035.453% |
| Xenetic Biosciences, Inc. | 10.6 Million USD | -7742.209% |
| Tenaya Therapeutics, Inc. | 170.51 Million USD | -387.748% |
| IGM Biosciences, Inc. | 423.41 Million USD | -96.425% |
| INmune Bio, Inc. | 57 Million USD | -1359.069% |
| Heron Therapeutics, Inc. | 222.5 Million USD | -273.78% |
| SAB Biotherapeutics, Inc. | 83.94 Million USD | -890.793% |
| Pasithea Therapeutics Corp. | 26.11 Million USD | -3084.472% |
| Entero Therapeutics, Inc. | 6.88 Million USD | -11982.819% |
| Milestone Pharmaceuticals Inc. | 75.22 Million USD | -1005.581% |
| X4 Pharmaceuticals, Inc. | 147.25 Million USD | -464.78% |
| Atara Biotherapeutics, Inc. | 165.5 Million USD | -402.516% |
| Coherus BioSciences, Inc. | 629.6 Million USD | -32.096% |
| Verastem, Inc. | 149.71 Million USD | -455.5% |
| Abeona Therapeutics Inc. | 64 Million USD | -1199.466% |
| Pliant Therapeutics, Inc. | 512.15 Million USD | -62.389% |
| Tonix Pharmaceuticals Holding Corp. | 154.45 Million USD | -438.457% |
| Histogen Inc. | 19.07 Million USD | -4260.531% |
| Aprea Therapeutics, Inc. | 22.65 Million USD | -3571.866% |
| Surrozen, Inc. | 46.08 Million USD | -1704.87% |
| Organovo Holdings, Inc. | 6.34 Million USD | -12999.449% |
| Lixte Biotechnology Holdings, Inc. | 4.3 Million USD | -19202.793% |
| Ovid Therapeutics Inc. | 144.02 Million USD | -477.451% |
| Panbela Therapeutics, Inc. | 11.8 Million USD | -6946.975% |
| CASI Pharmaceuticals, Inc. | 75.26 Million USD | -1004.964% |
| Cadrenal Therapeutics, Inc. Common Stock | 8.51 Million USD | -9662.409% |
| Centessa Pharmaceuticals plc | 362.96 Million USD | -129.134% |
| Hepion Pharmaceuticals, Inc. | 18.09 Million USD | -4496.362% |
| Arcturus Therapeutics Holdings Inc. | 429.4 Million USD | -93.684% |
| BioRestorative Therapies, Inc. | 12.61 Million USD | -6494.533% |
| Apollomics, Inc. | 55.38 Million USD | -1401.587% |
| Mesoblast Limited | 669.15 Million USD | -24.289% |
| Turnstone Biologics Corp. | 112.81 Million USD | -637.21% |
| Kymera Therapeutics, Inc. | 575.75 Million USD | -44.45% |
| Synaptogenix, Inc. | 31.11 Million USD | -2573.05% |
| Tiziana Life Sciences Ltd | 12.18 Million USD | -6726.034% |
| Aurinia Pharmaceuticals Inc. | 548.06 Million USD | -51.75% |
| BriaCell Therapeutics Corp. | 5.87 Million USD | -14062.926% |
| Monopar Therapeutics Inc. | 7.34 Million USD | -11222.886% |
| Exelixis, Inc. | 2.94 Billion USD | 71.734% |
| Better Therapeutics, Inc. | 22.94 Million USD | -3525.001% |
| Nurix Therapeutics, Inc. | 364.53 Million USD | -128.147% |
| Apellis Pharmaceuticals, Inc. | 788.73 Million USD | -5.446% |
| NLS Pharmaceutics AG | 1.84 Million USD | -44937.666% |
| Dermata Therapeutics, Inc. | 7.97 Million USD | -10323.89% |
| Aridis Pharmaceuticals, Inc. | 14.69 Million USD | -5559.639% |
| Gritstone bio, Inc. | 177.76 Million USD | -367.845% |
| Jasper Therapeutics, Inc. | 95.38 Million USD | -771.969% |
| TNF Pharmaceuticals, Inc. | 17.86 Million USD | -4556.094% |
| Avid Bioservices, Inc. | 336.55 Million USD | -147.115% |
| Insmed Incorporated | 1.32 Billion USD | 37.46% |
| Virpax Pharmaceuticals, Inc. | 9.62 Million USD | -8537.871% |
| MediWound Ltd. | 66.45 Million USD | -1151.424% |
| OmniAb, Inc. | 401.98 Million USD | -106.894% |
| Alector, Inc. | 621.82 Million USD | -33.748% |
| Seres Therapeutics, Inc. | 358.6 Million USD | -131.925% |
| Checkpoint Therapeutics, Inc. | 5.37 Million USD | -15364.559% |
| Viracta Therapeutics, Inc. | 56.69 Million USD | -1367.022% |
| Zai Lab Limited | 1.03 Billion USD | 19.744% |
| Revance Therapeutics, Inc. | 478.45 Million USD | -73.827% |
| Aura Biosciences, Inc. | 255.07 Million USD | -226.055% |
| Lyell Immunopharma, Inc. | 750.02 Million USD | -10.887% |
| Immunic, Inc. | 54.29 Million USD | -1431.675% |
| Tarsus Pharmaceuticals, Inc. | 266.22 Million USD | -212.4% |
| Veracyte, Inc. | 1.13 Billion USD | 26.906% |
| InMed Pharmaceuticals Inc. | 11.82 Million USD | -6934.588% |
| FibroGen, Inc. | 423.52 Million USD | -96.37% |
| SeaStar Medical Holding Corporation | 3.51 Million USD | -23574.466% |
| Adial Pharmaceuticals, Inc. | 4.73 Million USD | -17458.652% |
| Sonnet BioTherapeutics Holdings, Inc. | 5.42 Million USD | -15217.937% |
| Jazz Pharmaceuticals plc | 11.39 Billion USD | 92.7% |
| Cyclacel Pharmaceuticals, Inc. | 8.8 Million USD | -9345.588% |
| Amylyx Pharmaceuticals, Inc. | 517.45 Million USD | -60.726% |
| TG Therapeutics, Inc. | 329.58 Million USD | -152.341% |
| Galecto, Inc. | 38.22 Million USD | -2075.645% |
| Calithera Biosciences, Inc. | 28.67 Million USD | -2800.279% |
| Fortrea Holdings Inc. | 4.35 Billion USD | 80.912% |
| KalVista Pharmaceuticals, Inc. | 235.4 Million USD | -253.301% |
| Aptevo Therapeutics Inc. | 24.84 Million USD | -3247.895% |
| XBiotech Inc. | 227.24 Million USD | -265.989% |
| Jasper Therapeutics, Inc. | 95.38 Million USD | -771.969% |
| Lyra Therapeutics, Inc. | 142.6 Million USD | -483.229% |
| Foghorn Therapeutics Inc. | 285.91 Million USD | -190.884% |
| Y-mAbs Therapeutics, Inc. | 127.86 Million USD | -550.419% |
| Theravance Biopharma, Inc. | 381.99 Million USD | -117.719% |
| Ultragenyx Pharmaceutical Inc. | 1.49 Billion USD | 44.22% |
| Metagenomi, Inc. Common Stock | 364.84 Million USD | -127.957% |
| Vaxxinity, Inc. | 44.35 Million USD | -1775.147% |
| BioCryst Pharmaceuticals, Inc. | 516.96 Million USD | -60.88% |
| Gain Therapeutics, Inc. | 18.6 Million USD | -4369.177% |
| Cartesian Therapeutics, Inc. | 305.05 Million USD | -172.639% |
| NexImmune, Inc. | 8.59 Million USD | -9577.553% |
| Creative Medical Technology Holdings, Inc. | 10.71 Million USD | -7661.729% |
| Marker Therapeutics, Inc. | 17.12 Million USD | -4755.871% |
| Regeneron Pharmaceuticals, Inc. | 33.08 Billion USD | 97.486% |
| Chemomab Therapeutics Ltd. | 22.15 Million USD | -3654.589% |
| Scopus BioPharma Inc. | 392.26 Thousand USD | -211920.955% |
| RAPT Therapeutics, Inc. | 173.32 Million USD | -379.83% |
| Ainos, Inc. | 31.84 Million USD | -2511.925% |
| Pluri Inc. | 39.52 Million USD | -2004.091% |
| Prothena Corporation plc | 696.38 Million USD | -19.429% |
| Adaptimmune Therapeutics plc | 282.61 Million USD | -194.281% |
| Celularity Inc. | 143.88 Million USD | -478.004% |
| Rallybio Corporation | 115.62 Million USD | -619.325% |
| Cue Biopharma, Inc. | 61.53 Million USD | -1251.672% |
| MeiraGTx Holdings plc | 458.16 Million USD | -81.524% |
| Omeros Corporation | 378.26 Million USD | -119.866% |
| Humacyte, Inc. | 128.22 Million USD | -548.623% |
| Immunocore Holdings plc | 597 Million USD | -39.31% |
| Cocrystal Pharma, Inc. | 31.25 Million USD | -2560.623% |
| Cidara Therapeutics, Inc. | 68.53 Million USD | -1113.606% |
| Blueprint Medicines Corporation | 1.04 Billion USD | 20.735% |
| CalciMedica, Inc. | 12.18 Million USD | -6725.474% |
| Cabaletta Bio, Inc. | 253.65 Million USD | -227.886% |
| Marinus Pharmaceuticals, Inc. | 170.9 Million USD | -386.627% |
| Scholar Rock Holding Corporation | 311.03 Million USD | -167.392% |
| Sana Biotechnology, Inc. | 565.29 Million USD | -47.123% |
| Pulmatrix, Inc. | 33.95 Million USD | -2349.155% |
| Elicio Therapeutics, Inc. | 27.14 Million USD | -2963.744% |
| Vigil Neuroscience, Inc. | 140.85 Million USD | -490.441% |
| Intellia Therapeutics, Inc. | 1.3 Billion USD | 36.072% |
| Adlai Nortye Ltd. American Depositary Shares | 130.18 Million USD | -538.828% |
| Cytokinetics, Incorporated | 824.31 Million USD | -0.894% |
| Eloxx Pharmaceuticals, Inc. | 21.12 Million USD | -3837.338% |
| Nutriband Inc. | 7.51 Million USD | -10963.815% |
| Protara Therapeutics, Inc. | 78.95 Million USD | -953.378% |
| Vor Biopharma Inc. | 209.82 Million USD | -296.365% |
| Roivant Sciences Ltd. | 7.22 Billion USD | 88.485% |
| Evogene Ltd. | 51.1 Million USD | -1527.53% |
| ProKidney Corp. | 420.55 Million USD | -97.76% |
| Applied Therapeutics, Inc. | 54.83 Million USD | -1416.758% |
| Hoth Therapeutics, Inc. | 9.52 Million USD | -8635.921% |
| BridgeBio Pharma, Inc. | 546.38 Million USD | -52.217% |
| CorMedix Inc. | 82.05 Million USD | -913.508% |
| BioLineRx Ltd. | 63.92 Million USD | -1201.031% |
| Tango Therapeutics, Inc. | 402.56 Million USD | -106.595% |
| Galectin Therapeutics Inc. | 28.2 Million USD | -2849.234% |
| Atai Life Sciences N.V. | 293.47 Million USD | -183.389% |
| Renovaro Biosciences Inc. | 163.12 Million USD | -409.831% |
| Aerovate Therapeutics, Inc. | 127.41 Million USD | -552.721% |
| Zentalis Pharmaceuticals, Inc. | 562.02 Million USD | -47.979% |
| Sagimet Biosciences Inc. | 96.71 Million USD | -759.897% |
| MediciNova, Inc. | 66.26 Million USD | -1154.994% |
| Praxis Precision Medicines, Inc. | 87.94 Million USD | -845.654% |
| Cardio Diagnostics Holdings, Inc. | 4.46 Million USD | -18537.74% |
| GeoVax Labs, Inc. | 9.28 Million USD | -8859.004% |
| Axsome Therapeutics, Inc. | 588.23 Million USD | -41.386% |
| Biomea Fusion, Inc. | 199.92 Million USD | -315.994% |
| PTC Therapeutics, Inc. | 1.9 Billion USD | 56.3% |
| Mereo BioPharma Group plc | 66.49 Million USD | -1150.671% |
| Cullinan Oncology, Inc. | 485.09 Million USD | -71.447% |
| Syndax Pharmaceuticals, Inc. | 612.88 Million USD | -35.701% |
| Absci Corporation | 234.48 Million USD | -254.693% |
| NRx Pharmaceuticals, Inc. | 7.31 Million USD | -11269.569% |
| 4D Molecular Therapeutics, Inc. | 339.89 Million USD | -144.691% |
| Dyne Therapeutics, Inc. | 165.08 Million USD | -403.801% |
| Kiniksa Pharmaceuticals, Ltd. | 526.32 Million USD | -58.018% |
| Ventyx Biosciences, Inc. | 277.69 Million USD | -199.498% |
| Allakos Inc. | 243.61 Million USD | -241.4% |
| Imunon, Inc. | 21.91 Million USD | -3694.513% |
| Fulcrum Therapeutics, Inc. | 257.69 Million USD | -222.741% |
| Corcept Therapeutics Incorporated | 621.51 Million USD | -33.815% |
| BioAtla, Inc. | 119.65 Million USD | -595.051% |
| NLS Pharmaceutics AG | 1.84 Million USD | -44937.666% |
| Bio-Path Holdings, Inc. | 3.22 Million USD | -25728.696% |
| Allogene Therapeutics, Inc. | 642.83 Million USD | -29.377% |
| Larimar Therapeutics, Inc. | 95.93 Million USD | -766.924% |
| XOMA Corporation | 234.3 Million USD | -254.964% |
| Kezar Life Sciences, Inc. | 221.23 Million USD | -275.928% |
| Cara Therapeutics, Inc. | 125.84 Million USD | -560.885% |
| aTyr Pharma, Inc. | 122.06 Million USD | -581.334% |
| Aligos Therapeutics, Inc. | 153.9 Million USD | -440.395% |
| Akero Therapeutics, Inc. | 580.27 Million USD | -43.327% |
| Viridian Therapeutics, Inc. | 490.42 Million USD | -69.585% |
| Eliem Therapeutics, Inc. | 110.46 Million USD | -652.866% |
| EyeGate Pharmaceuticals, Inc. | 15.15 Million USD | -5386.926% |
| Akari Therapeutics, Plc | 4.35 Million USD | -18997.222% |
| Tevogen Bio Holdings Inc. | 17.03 Million USD | -4781.539% |
| Halozyme Therapeutics, Inc. | 1.73 Billion USD | 52.016% |
| Lexaria Bioscience Corp. | 3.08 Million USD | -26867.827% |
| UroGen Pharma Ltd. | 178.31 Million USD | -366.423% |
| Sutro Biopharma, Inc. | 470.73 Million USD | -76.677% |
| ZIVO Bioscience, Inc. | 555.71 Thousand USD | -149560.168% |
| Orgenesis Inc. | 14.55 Million USD | -5615.256% |
| Entera Bio Ltd. | 11.76 Million USD | -6969.137% |
| GH Research PLC | 226.3 Million USD | -267.514% |
| Lisata Therapeutics, Inc. | 54.69 Million USD | -1420.613% |
| Reneo Pharmaceuticals, Inc. | 107.43 Million USD | -674.12% |
| Xencor, Inc. | 952.69 Million USD | 12.702% |
| 60 Degrees Pharmaceuticals, Inc. | 7.78 Million USD | -10584.847% |
| Replimune Group, Inc. | 487.72 Million USD | -70.524% |
| Coeptis Therapeutics Holdings, Inc. | 8.07 Million USD | -10204.483% |
| Vanda Pharmaceuticals Inc. | 648.44 Million USD | -28.259% |
| Lexaria Bioscience Corp. | 3.08 Million USD | -26867.827% |
| Portage Biotech Inc. | 7.77 Million USD | -10591.4% |
| Cardio Diagnostics Holdings, Inc. | 4.46 Million USD | -18537.74% |
| Olema Pharmaceuticals, Inc. | 276.94 Million USD | -200.307% |
| OncoCyte Corporation | 74.89 Million USD | -1010.511% |
| Qualigen Therapeutics, Inc. | 2.03 Million USD | -40804.208% |
| Processa Pharmaceuticals, Inc. | 5.78 Million USD | -14272.478% |
| Purple Biotech Ltd. | 44.3 Million USD | -1777.306% |
| CollPlant Biotechnologies Ltd. | 34.12 Million USD | -2337.098% |
| scPharmaceuticals Inc. | 94.47 Million USD | -780.285% |
| ProMIS Neurosciences, Inc. | 18.04 Million USD | -4508.955% |
| HilleVax, Inc. | 344.43 Million USD | -141.464% |
| NeuroSense Therapeutics Ltd. | 3.17 Million USD | -26086.524% |
| Tharimmune, Inc. | 10.94 Million USD | -7497.79% |
| Genprex, Inc. | 10.67 Million USD | -7694.169% |
| Neumora Therapeutics, Inc. Common Stock | 496.19 Million USD | -67.612% |
| Atossa Therapeutics, Inc. | 96.25 Million USD | -764.069% |
| XTL Biopharmaceuticals Ltd. | 2.42 Million USD | -34182.11% |
| Virios Therapeutics, Inc. | 4.16 Million USD | -19866.289% |
| OKYO Pharma Limited | 1.54 Million USD | -53861.164% |
| Savara Inc. | 177.56 Million USD | -368.385% |
| Curis, Inc. | 77.28 Million USD | -976.168% |
| Daré Bioscience, Inc. | 21.28 Million USD | -3807.883% |
| Carmell Therapeutics Corporation | 63.94 Million USD | -1200.547% |
| Titan Pharmaceuticals, Inc. | 8.08 Million USD | -10185.481% |
| Achieve Life Sciences, Inc. | 19.37 Million USD | -4193.449% |
| BeiGene, Ltd. | 5.8 Billion USD | 85.674% |
| Kiromic BioPharma, Inc. | 12.16 Million USD | -6734.448% |
| Revolution Medicines, Inc. Warrant | 2.08 Billion USD | 60.18% |
| Protagonist Therapeutics, Inc. | 357.95 Million USD | -132.346% |
| Erasca, Inc. | 395.29 Million USD | -110.395% |
| bluebird bio, Inc. | 619.16 Million USD | -34.324% |
| Protagenic Therapeutics, Inc. | 4.32 Million USD | -19136.942% |
| BioMarin Pharmaceutical Inc. | 6.84 Billion USD | 87.844% |
| DBV Technologies S.A. | 182.98 Million USD | -354.507% |
| Protagenic Therapeutics, Inc. | 4.32 Million USD | -19136.942% |
| Moderna, Inc. | 18.42 Billion USD | 95.486% |
| Vincerx Pharma, Inc. | 18.21 Million USD | -4465.428% |
| Fresh Tracks Therapeutics, Inc. | 11.58 Million USD | -7078.353% |
| Molecular Templates, Inc. | 35.38 Million USD | -2250.519% |
| Acrivon Therapeutics, Inc. Common Stock | 138.26 Million USD | -501.514% |
| Travere Therapeutics, Inc. | 788.91 Million USD | -5.422% |
| Monte Rosa Therapeutics, Inc. | 303.75 Million USD | -173.801% |
| Spruce Biosciences, Inc. | 103.94 Million USD | -700.112% |
| Celldex Therapeutics, Inc. | 465.62 Million USD | -78.616% |
| Cogent Biosciences, Inc. | 313.43 Million USD | -165.343% |
| MacroGenics, Inc. | 306.82 Million USD | -171.066% |
| RenovoRx, Inc. | 1.46 Million USD | -56631.514% |
| Adicet Bio, Inc. | 207.29 Million USD | -301.208% |
| Prime Medicine, Inc. | 193.85 Million USD | -329.033% |
| Aditxt, Inc. | 44.57 Million USD | -1765.669% |
| Adagene Inc. | 115.72 Million USD | -618.649% |
| Estrella Immunopharma, Inc. | 4.45 Million USD | -18571.951% |
| Quantum-Si incorporated | 298.25 Million USD | -178.855% |
| Maravai LifeSciences Holdings, Inc. | 1.48 Billion USD | 44.087% |
| Acurx Pharmaceuticals, Inc. | 7.7 Million USD | -10688.309% |
| Voyager Therapeutics, Inc. | 351.28 Million USD | -136.757% |
| SciSparc Ltd. | 11.18 Million USD | -7337.703% |
| Vericel Corporation | 353.65 Million USD | -135.167% |
| Revelation Biosciences, Inc. | 12.21 Million USD | -6710.044% |
| Minerva Neurosciences, Inc. | 56.9 Million USD | -1361.643% |
| Generation Bio Co. | 374.75 Million USD | -121.926% |
| Astria Therapeutics, Inc. | 254.66 Million USD | -226.578% |
| Black Diamond Therapeutics, Inc. | 158.56 Million USD | -424.5% |
| Arcutis Biotherapeutics, Inc. | 341.36 Million USD | -143.635% |
| Invivyd, Inc. | 229.18 Million USD | -262.894% |
| Relay Therapeutics, Inc. | 843.98 Million USD | 1.457% |
| Quoin Pharmaceuticals, Ltd. | 12.16 Million USD | -6734.279% |
| Spero Therapeutics, Inc. | 182.39 Million USD | -355.992% |
| Artelo Biosciences, Inc. | 20.42 Million USD | -3972.092% |
| 2seventy bio, Inc. | 565.42 Million USD | -47.09% |
| ADMA Biologics, Inc. | 329.18 Million USD | -152.652% |
| Clene Inc. | 52.34 Million USD | -1488.972% |
| Capricor Therapeutics, Inc. | 58.73 Million USD | -1316.01% |
| Boundless Bio, Inc. Common Stock | 129.89 Million USD | -540.279% |
| GeoVax Labs, Inc. | 9.28 Million USD | -8859.004% |
| Recursion Pharmaceuticals, Inc. | 653.69 Million USD | -27.227% |
| Citius Pharmaceuticals, Inc. | 103.61 Million USD | -702.697% |
| Contineum Therapeutics, Inc. Class A Common Stock | 130.38 Million USD | -537.863% |
| Relmada Therapeutics, Inc. | 97.55 Million USD | -752.554% |
| Finch Therapeutics Group, Inc. | 70.99 Million USD | -1071.435% |
| ALX Oncology Holdings Inc. | 242.55 Million USD | -242.888% |
| Vir Biotechnology, Inc. | 1.96 Billion USD | 57.569% |
| Evaxion Biotech A/S | 12.88 Million USD | -6352.856% |
| Ocular Therapeutix, Inc. | 252.06 Million USD | -229.955% |
| Verve Therapeutics, Inc. | 752.68 Million USD | -10.495% |
| Trevena, Inc. | 40.6 Million USD | -1948.231% |
| Surrozen, Inc. | 46.08 Million USD | -1704.87% |
| Tyra Biosciences, Inc. | 225.85 Million USD | -268.235% |
| Cingulate Inc. | 3.49 Million USD | -23720.686% |
| Galmed Pharmaceuticals Ltd. | 16.62 Million USD | -4901.407% |
| Unity Biotechnology, Inc. | 65.69 Million USD | -1166.074% |
| Tenax Therapeutics, Inc. | 11.68 Million USD | -7017.763% |
| Terns Pharmaceuticals, Inc. | 268.51 Million USD | -209.732% |
| ACADIA Pharmaceuticals Inc. | 748.95 Million USD | -11.046% |
| Connect Biopharma Holdings Limited | 125.89 Million USD | -560.633% |
| Clearmind Medicine Inc. | 4.32 Million USD | -19132.405% |
| Kronos Bio, Inc. | 213.27 Million USD | -289.951% |
| Bolt Biotherapeutics, Inc. | 159.78 Million USD | -420.505% |
| CERo Therapeutics Holdings, Inc. | 8.56 Million USD | -9615.242% |
| Viking Therapeutics, Inc. | 368.49 Million USD | -125.701% |
| Statera Biopharma, Inc. | 21.16 Million USD | -3828.656% |
| ImmunityBio, Inc. | 504.45 Million USD | -64.869% |
| Korro Bio, Inc. | 221.66 Million USD | -275.202% |
| Kineta, Inc. | 10.28 Million USD | -7989.524% |
| BioVie Inc. | 25.2 Million USD | -3199.241% |
| Codexis, Inc. | 136.56 Million USD | -509.02% |
| Celularity Inc. | 143.88 Million USD | -478.004% |
| Crinetics Pharmaceuticals, Inc. | 635.35 Million USD | -30.901% |
| Celcuity Inc. | 191.21 Million USD | -334.937% |
| Virax Biolabs Group Limited | 5.48 Million USD | -15065.731% |
| Cibus, Inc. | 544.41 Million USD | -52.768% |
| Eledon Pharmaceuticals, Inc. | 125.89 Million USD | -560.622% |
| eFFECTOR Therapeutics, Inc. | 20.54 Million USD | -3948.306% |
| IN8bio, Inc. | 33.7 Million USD | -2367.246% |
| Kodiak Sciences Inc. | 479.37 Million USD | -73.494% |
| Annexon, Inc. | 297.67 Million USD | -179.394% |
| Adverum Biotechnologies, Inc. | 173.01 Million USD | -380.714% |
| Assembly Biosciences, Inc. | 137.46 Million USD | -504.997% |
| Avalo Therapeutics, Inc. | 20.99 Million USD | -3861.721% |
| Ionis Pharmaceuticals, Inc. | 2.99 Billion USD | 72.185% |
| Eyenovia, Inc. | 28.77 Million USD | -2789.861% |
| Puma Biotechnology, Inc. | 230.52 Million USD | -260.774% |
| Conduit Pharmaceuticals Inc. | 7.22 Million USD | -11412.791% |
| Xilio Therapeutics, Inc. | 60.92 Million USD | -1265.072% |
| Arcellx, Inc. | 825.13 Million USD | -0.794% |
| Cardiff Oncology, Inc. | 81.63 Million USD | -918.759% |
| Enanta Pharmaceuticals, Inc. | 462.27 Million USD | -79.911% |
| Regulus Therapeutics Inc. | 30.75 Million USD | -2604.663% |
| Moolec Science SA | 24.05 Million USD | -3357.96% |
| Acumen Pharmaceuticals, Inc. | 310.12 Million USD | -168.177% |
| Geron Corporation | 394.07 Million USD | -111.047% |
| LAVA Therapeutics N.V. | 101.71 Million USD | -717.701% |
| Royalty Pharma plc | 16.38 Billion USD | 94.923% |
| Atea Pharmaceuticals, Inc. | 594.96 Million USD | -39.786% |
| Greenwich LifeSciences, Inc. | 6.99 Million USD | -11790.007% |
| TFF Pharmaceuticals, Inc. | 12.02 Million USD | -6814.959% |
| Mersana Therapeutics, Inc. | 226.06 Million USD | -267.904% |
| Humacyte, Inc. | 128.22 Million USD | -548.623% |
| Structure Therapeutics Inc. | 482.01 Million USD | -72.542% |
| 89bio, Inc. | 596.26 Million USD | -39.481% |
| PMV Pharmaceuticals, Inc. | 252.15 Million USD | -229.834% |
| Avenue Therapeutics, Inc. | 1.85 Million USD | -44855.892% |
| Genelux Corporation | 27.89 Million USD | -2881.694% |
| Trevi Therapeutics, Inc. | 89.4 Million USD | -830.264% |
| Lexicon Pharmaceuticals, Inc. | 229.42 Million USD | -262.502% |
| Notable Labs, Ltd. | 19.54 Million USD | -4156.097% |
| Liquidia Corporation | 120.43 Million USD | -590.59% |
| Mustang Bio, Inc. | 17.74 Million USD | -4587.656% |
| Immunovant, Inc. | 666.71 Million USD | -24.744% |
| Quantum-Si incorporated | 298.25 Million USD | -178.855% |
| Arbutus Biopharma Corporation | 144.4 Million USD | -475.954% |
| DiaMedica Therapeutics Inc. | 54.16 Million USD | -1435.606% |
| Vera Therapeutics, Inc. | 175.54 Million USD | -373.77% |
| Acasti Pharma Inc. | 73.3 Million USD | -1034.63% |
| MiNK Therapeutics, Inc. | 4.55 Million USD | -18169.61% |
| Pasithea Therapeutics Corp. | 26.11 Million USD | -3084.472% |
| Xenon Pharmaceuticals Inc. | 964.79 Million USD | 13.797% |
| Elevai Labs, Inc. Common Stock | 5.18 Million USD | -15924.993% |
| NeuroBo Pharmaceuticals, Inc. | 22.78 Million USD | -3550.779% |
| Tempest Therapeutics, Inc. | 51.6 Million USD | -1511.697% |
| Soleno Therapeutics, Inc. | 180.69 Million USD | -360.28% |
| PepGen Inc. | 143.05 Million USD | -481.386% |
| Moleculin Biotech, Inc. | 38.21 Million USD | -2076.215% |
| United Therapeutics Corporation | 7.16 Billion USD | 88.396% |
| Nuvectis Pharma, Inc. | 19.18 Million USD | -4235.074% |
| Solid Biosciences Inc. | 164.93 Million USD | -404.237% |
| BriaCell Therapeutics Corp. | 5.87 Million USD | -14062.926% |
| Immuneering Corporation | 102.58 Million USD | -710.73% |
| Lixte Biotechnology Holdings, Inc. | 4.3 Million USD | -19202.793% |
| Silo Pharma, Inc. | 7.74 Million USD | -10636.753% |
| Belite Bio, Inc | 94.64 Million USD | -778.768% |
| XOMA Corporation | 234.3 Million USD | -254.964% |
| ARS Pharmaceuticals, Inc. | 233.18 Million USD | -256.658% |
| Bionomics Limited | 27.64 Million USD | -2907.997% |
| Apogee Therapeutics, Inc. | 401.4 Million USD | -107.194% |
| Alpha Tau Medical Ltd. | 107.38 Million USD | -674.466% |
| uniQure N.V. | 831.68 Million USD | 0.001% |
| Cassava Sciences, Inc. | 151.66 Million USD | -448.376% |
| Estrella Immunopharma, Inc. | 4.45 Million USD | -18571.951% |
| Poseida Therapeutics, Inc. | 273.88 Million USD | -203.662% |
| Forte Biosciences, Inc. | 38.98 Million USD | -2033.617% |
| Anebulo Pharmaceuticals, Inc. | 4.07 Million USD | -20318.874% |
| Enlivex Therapeutics Ltd. | 36.83 Million USD | -2158.109% |
| Conduit Pharmaceuticals Inc. | 7.22 Million USD | -11412.791% |
| SeaStar Medical Holding Corporation | 3.51 Million USD | -23574.466% |
| FibroBiologics, Inc. Common Stock | 11.82 Million USD | -6935.648% |
| Altimmune, Inc. | 210.64 Million USD | -294.837% |
| Amicus Therapeutics, Inc. | 777.88 Million USD | -6.917% |
| Alpha Tau Medical Ltd. | 107.38 Million USD | -674.466% |
| Compugen Ltd. | 121.33 Million USD | -585.45% |
| Peak Bio, Inc. | 2.59 Million USD | -31932.013% |
| Zevra Therapeutics, Inc. | 172.32 Million USD | -382.62% |
| Benitec Biopharma Inc. | 52.21 Million USD | -1492.959% |
| Spyre Therapeutics, Inc. | 341.85 Million USD | -143.283% |
| NKGen Biotech, Inc. Common Stock | 34.77 Million USD | -2291.752% |
| Zura Bio Limited | 100.84 Million USD | -724.732% |
| PolyPid Ltd. | 15.37 Million USD | -5310.383% |
| Aileron Therapeutics, Inc. | 119.28 Million USD | -597.218% |
| NKGen Biotech, Inc. Warrants | 34.77 Million USD | -2291.752% |
| Instil Bio, Inc. | 325.63 Million USD | -155.408% |
| argenx SE | 4.54 Billion USD | 81.691% |
| Immunome, Inc. | 148.54 Million USD | -459.906% |
| Compass Therapeutics, Inc. | 156.87 Million USD | -430.157% |
| Verona Pharma plc | 308.12 Million USD | -169.919% |
| enGene Holdings Inc. Warrants | 86.95 Million USD | -856.409% |
| Shattuck Labs, Inc. | 159.56 Million USD | -421.223% |
| CervoMed Inc. | 9.97 Million USD | -8239.757% |
| LENZ Therapeutics, Inc. | 188.45 Million USD | -341.315% |
| Plus Therapeutics, Inc. | 11.38 Million USD | -7203.161% |
| Dianthus Therapeutics, Inc. | 179.4 Million USD | -363.579% |
| Moolec Science SA | 24.05 Million USD | -3357.96% |
| Enveric Biosciences, Inc. | 6.11 Million USD | -13495.206% |
| Inovio Pharmaceuticals, Inc. | 172.94 Million USD | -380.897% |
| AnaptysBio, Inc. | 452.38 Million USD | -83.843% |
| Design Therapeutics, Inc. | 289.64 Million USD | -187.141% |
| Leap Therapeutics, Inc. | 72.82 Million USD | -1042.031% |
| NeurAxis, Inc. | 509.49 Thousand USD | -163135.97% |
| Seelos Therapeutics, Inc. | 5.41 Million USD | -15250.388% |
| Lumos Pharma, Inc. | 40.63 Million USD | -1946.567% |
| Achilles Therapeutics plc | 161.45 Million USD | -415.115% |
| enGene Holdings Inc. Common Stock | 86.95 Million USD | -856.409% |
| 180 Life Sciences Corp. | 5.25 Million USD | -15713.058% |
| Opiant Pharmaceuticals, Inc. | 70.42 Million USD | -1080.903% |
| CERo Therapeutics Holdings, Inc. | 8.56 Million USD | -9615.242% |
| Nutriband Inc. | 7.51 Million USD | -10963.815% |
| ORIC Pharmaceuticals, Inc. | 254.68 Million USD | -226.553% |
| CG Oncology, Inc. Common stock | 199.3 Million USD | -317.3% |
| Fractyl Health, Inc. Common Stock | 76.21 Million USD | -991.277% |
| Rani Therapeutics Holdings, Inc. | 57.91 Million USD | -1336.018% |
| MoonLake Immunotherapeutics | 526.54 Million USD | -57.953% |
| Palisade Bio, Inc. | 14.05 Million USD | -5818.617% |
| Tourmaline Bio, Inc. | 210.29 Million USD | -295.484% |
| Beam Therapeutics Inc. | 1.45 Billion USD | 43.024% |
| Neurogene Inc. | 222.57 Million USD | -273.668% |
| Mirum Pharmaceuticals, Inc. | 646.62 Million USD | -28.62% |
| AEON Biopharma, Inc. | 6.84 Million USD | -12050.241% |
| CARGO Therapeutics, Inc. Common Stock | 453.03 Million USD | -83.58% |
| Sesen Bio, Inc. | 189.17 Million USD | -339.64% |
| Enliven Therapeutics, Inc. | 271.86 Million USD | -205.916% |
| Kiora Pharmaceuticals, Inc. | 13.71 Million USD | -5965.431% |
| Iovance Biotherapeutics, Inc. | 780.35 Million USD | -6.578% |
| Taysha Gene Therapies, Inc. | 266.99 Million USD | -211.499% |
| Athira Pharma, Inc. | 160.24 Million USD | -419.008% |
| Vaccinex, Inc. | 3.63 Million USD | -22805.095% |
| HCW Biologics Inc. | 28.51 Million USD | -2816.791% |
| XOMA Corporation | 234.3 Million USD | -254.964% |
| Nektar Therapeutics | 398.03 Million USD | -108.949% |
| Arvinas, Inc. | 1.3 Billion USD | 36.25% |
| Tevogen Bio Holdings Inc. | 17.03 Million USD | -4781.539% |
| Merus N.V. | 458.49 Million USD | -81.395% |
| Omega Therapeutics, Inc. | 204.36 Million USD | -306.958% |
| Quince Therapeutics, Inc. | 180.2 Million USD | -361.524% |
| Rezolute, Inc. | 132.73 Million USD | -526.565% |
| Clene Inc. | 52.34 Million USD | -1488.972% |
| Indaptus Therapeutics, Inc. | 14.92 Million USD | -5472.841% |
| BeyondSpring Inc. | 24.8 Million USD | -3252.483% |
| Synlogic, Inc. | 75.55 Million USD | -1000.839% |
| Allarity Therapeutics, Inc. | 11.86 Million USD | -6911.33% |
| Phio Pharmaceuticals Corp. | 9.36 Million USD | -8781.717% |
| Peak Bio, Inc. | 2.59 Million USD | -31932.013% |
| Werewolf Therapeutics, Inc. | 174.83 Million USD | -375.702% |
| Krystal Biotech, Inc. | 818.35 Million USD | -1.629% |
| Karyopharm Therapeutics Inc. | 240.43 Million USD | -245.904% |
| SpringWorks Therapeutics, Inc. | 725.78 Million USD | -14.59% |
| Lipella Pharmaceuticals Inc. | 3.57 Million USD | -23149.75% |
| MannKind Corporation | 475.19 Million USD | -75.018% |
| Ikena Oncology, Inc. | 192.09 Million USD | -332.961% |
| Cyclerion Therapeutics, Inc. | 13.37 Million USD | -6118.663% |
| Gyre Therapeutics, Inc. | 116.53 Million USD | -613.653% |
| Gossamer Bio, Inc. | 311.91 Million USD | -166.637% |
| CohBar, Inc. | 16.36 Million USD | -4981.883% |
| Cognition Therapeutics, Inc. | 35.16 Million USD | -2265.225% |
| NRx Pharmaceuticals, Inc. | 7.31 Million USD | -11269.569% |
| Legend Biotech Corporation | 1.84 Billion USD | 55.01% |
| Mural Oncology plc | 301.74 Million USD | -175.625% |
| Biora Therapeutics, Inc. | 31.21 Million USD | -2564.373% |
| PaxMedica, Inc. Common Stock | 5.68 Million USD | -14541.28% |
| Disc Medicine, Inc. | 367.99 Million USD | -126.004% |
| Champions Oncology, Inc. | 26.13 Million USD | -3082.627% |
| REGENXBIO Inc. | 573.97 Million USD | -44.9% |
| Ensysce Biosciences, Inc. | 2.7 Million USD | -30611.148% |
| Anavex Life Sciences Corp. | 154.38 Million USD | -438.704% |
| Cellectar Biosciences, Inc. | 12.07 Million USD | -6787.321% |
| Edgewise Therapeutics, Inc. | 340.03 Million USD | -144.588% |
| Vaxart, Inc. | 91.83 Million USD | -805.678% |
| PharmaCyte Biotech, Inc. | 59.9 Million USD | -1288.364% |
| Aldeyra Therapeutics, Inc. | 148.32 Million USD | -460.71% |
| Cellectis S.A. | 334.27 Million USD | -148.806% |
| Longeveron Inc. | 12.17 Million USD | -6729.397% |
| Repare Therapeutics Inc. | 253.9 Million USD | -227.562% |
| Sarepta Therapeutics, Inc. | 3.26 Billion USD | 74.524% |
| Inozyme Pharma, Inc. | 200.84 Million USD | -314.088% |
| Revolution Medicines, Inc. | 2.08 Billion USD | 60.18% |
| Nymox Pharmaceutical Corporation | 1.62 Million USD | -51080.554% |
| Third Harmonic Bio, Inc. | 277.71 Million USD | -199.478% |
| ArriVent BioPharma, Inc. Common Stock | 163.09 Million USD | -409.929% |
| AN2 Therapeutics, Inc. | 138.74 Million USD | -499.438% |
| Anixa Biosciences, Inc. | 25.52 Million USD | -3158.694% |
| Vertex Pharmaceuticals Incorporated | 22.73 Billion USD | 96.341% |
| Denali Therapeutics Inc. | 1.15 Billion USD | 27.925% |
| Revelation Biosciences, Inc. | 12.21 Million USD | -6710.044% |
| Veru Inc. | 50.59 Million USD | -1543.777% |
| Corvus Pharmaceuticals, Inc. | 45.55 Million USD | -1725.75% |
| Cingulate Inc. | 3.49 Million USD | -23720.686% |
| Passage Bio, Inc. | 150.54 Million USD | -452.449% |
| Context Therapeutics Inc. | 16.06 Million USD | -5077.723% |
| Exicure, Inc. | 11.58 Million USD | -7082.073% |
| Day One Biopharmaceuticals, Inc. | 376.04 Million USD | -121.164% |
| Oramed Pharmaceuticals Inc. | 161.64 Million USD | -414.522% |
| Scinai Immunotherapeutics Ltd. | 17.47 Million USD | -4660.096% |
| Rhythm Pharmaceuticals, Inc. | 332.74 Million USD | -149.946% |
| Nuvalent, Inc. | 732.38 Million USD | -13.558% |
| ABVC BioPharma, Inc. | 14.94 Million USD | -5465.308% |
| Carisma Therapeutics, Inc. | 89.55 Million USD | -828.696% |
| Unicycive Therapeutics, Inc. | 14.19 Million USD | -5760.644% |
| OmniAb, Inc. | 401.98 Million USD | -106.894% |
| Anew Medical, Inc. | 19.45 Million USD | -4174.702% |
| Fennec Pharmaceuticals Inc. | 26.72 Million USD | -3011.826% |
| Lipocine Inc. | 23 Million USD | -3515.849% |
| Lexeo Therapeutics, Inc. Common Stock | 139.8 Million USD | -494.88% |
| Nautilus Biotechnology, Inc. | 305.56 Million USD | -172.179% |
| SAB Biotherapeutics, Inc. | 83.94 Million USD | -890.793% |
| G1 Therapeutics, Inc. | 121.54 Million USD | -584.288% |
| Bellerophon Therapeutics, Inc. | 7.93 Million USD | -10381.21% |
| Sage Therapeutics, Inc. | 882.27 Million USD | 5.734% |
| Ocugen, Inc. | 64.54 Million USD | -1188.494% |
| Mind Medicine (MindMed) Inc. | 124.54 Million USD | -567.799% |
| Q32 Bio Inc. | 306.11 Million USD | -171.687% |
| Brainstorm Cell Therapeutics Inc. | 4.2 Million USD | -19664.354% |
| Alumis Inc. Common Stock | 89.61 Million USD | -828.094% |
| Equillium, Inc. | 50.53 Million USD | -1545.921% |
| Kyverna Therapeutics, Inc. | 75.19 Million USD | -1006.036% |
| Coya Therapeutics, Inc. | 41.27 Million USD | -1915.054% |
| CNS Pharmaceuticals, Inc. | 1.7 Million USD | -48798.053% |
| Galera Therapeutics, Inc. | 26.14 Million USD | -3081.531% |
| Evelo Biosciences, Inc. | 64.44 Million USD | -1190.613% |
| Comera Life Sciences Holdings, Inc. | 3.72 Million USD | -22214.429% |
| Dominari Holdings Inc. | 57.55 Million USD | -1344.949% |
| Edesa Biotech, Inc. | 8.89 Million USD | -9254.816% |
| vTv Therapeutics Inc. | 11.01 Million USD | -7448.412% |
| Bio-Techne Corporation | 2.81 Billion USD | 70.436% |
| Agios Pharmaceuticals, Inc. | 937.11 Million USD | 11.251% |
| Harmony Biosciences Holdings, Inc. | 811.44 Million USD | -2.494% |
| Prelude Therapeutics Incorporated | 277.66 Million USD | -199.528% |
| Candel Therapeutics, Inc. | 41.7 Million USD | -1894.35% |
| iTeos Therapeutics, Inc. | 667.58 Million USD | -24.58% |
| Nkarta, Inc. | 378.88 Million USD | -119.508% |
| BioCardia, Inc. | 2.98 Million USD | -27743.455% |
| Iterum Therapeutics plc | 26.25 Million USD | -3067.234% |